Publication:
The role of inflammation and allergy in acute coronary syndromes

dc.contributor.authorÖZBEN SADIÇ, BESTE
dc.contributor.authorERDOĞAN, OKAN
dc.contributor.authorsOzben B., Erdogan O.
dc.date.accessioned2022-03-15T01:56:17Z
dc.date.accessioned2026-01-10T18:32:45Z
dc.date.available2022-03-15T01:56:17Z
dc.date.issued2008
dc.description.abstractIt is well known that inflammatory mechanisms play a crucial role in the pathogenesis of atherosclerosis and coronary artery disease. In recent years, allergic episodes have been shown to be associated with acute coronary syndromes. Mast cells release certain inflammatory mediators including histamine and neutral proteases during an allergic episode and these inflammatory mediators are implied to induce coronary artery spasm and/or atheromatous plaque erosion or rupture. As the inflammatory component of acute coronary syndromes is a potential therapeutic target, drugs that stabilize mast cell membrane and monoclonal antibodies that protect mast cell surface may be effective in preventing allergy associated acute coronary syndromes. In this review, we will mention the role of inflammation and allergy and anti-inflammatory therapeutic modalities in acute coronary syndromes. © 2008 Bentham Science Publishers Ltd.
dc.identifier.doi10.2174/187152808785748128
dc.identifier.issn18715281
dc.identifier.pubmed18782020
dc.identifier.urihttps://hdl.handle.net/11424/246855
dc.language.isoeng
dc.relation.ispartofInflammation and Allergy - Drug Targets
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAcute coronary syndromes (ACS)
dc.subjectAllergy
dc.subjectCoronary artery disease
dc.subjectInflammation
dc.subjectInflammatory mediators
dc.subjectMast cell
dc.subjectPathogenesis
dc.titleThe role of inflammation and allergy in acute coronary syndromes
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage144
oaire.citation.issue3
oaire.citation.startPage136
oaire.citation.titleInflammation and Allergy - Drug Targets
oaire.citation.volume7

Files